Literature DB >> 15472099

Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome.

Maria E Baldwin1, R Loch Macdonald, Dezheng Huo, Roberta L Novakovic, Roberta L Novakovia, Fernando D Goldenberg, Jeffrey I Frank, Axel J Rosengart.   

Abstract

BACKGROUND AND
PURPOSE: Early vasospasm (EVSP), defined here as arterial narrowing seen on diagnostic angiography within the first 48 hours of aneurysmal rupture, is a rarely reported and poorly defined phenomenon in patients with subarachnoid hemorrhage (SAH). The purpose of this study was to characterize EVSP in a large database of such patients.
METHODS: We analyzed the relationship of EVSP to clinical characteristics, in-hospital complications, and outcome at 3 months among 3478 patients entered into 4 prospective, randomized, double-blind, placebo-controlled trials of tirilazad conducted in neurosurgical centers around the world between 1991 and 1997.
RESULTS: Three hundred thirty-nine (10%) of 3478 patients had EVSP. EVSP was significantly more likely in patients with poor neurological grade on admission, history of SAH, intracerebral hematoma, larger aneurysm, thick SAH on cranial computed tomography, and intraventricular hemorrhage. EVSP was not associated with delayed cerebral vasospasm. After adjustment for differences in admission characteristics, EVSP was associated with cerebral infarction (adjusted odds ratios [OR]=1.51; 95% CI, 1.18 to 1.94; P=0.001), neurological worsening (OR=1.41; 95% CI, 1.10 to 1.81; P=0.007), and unfavorable outcome (OR=1.51; 95% CI, 1.15 to 2.00; P=0.003). In addition, there was a trend for patients with increasingly severe EVSP to have unfavorable outcome (OR=1.84 for mild and OR=2.66 for moderate/severe EVSP).
CONCLUSIONS: EVSP was seen in 10% of SAH patients and was predictive of cerebral infarction and neurological worsening as well as unfavorable outcome at 3 months. EVSP was not associated with late vasospasm. EVSP may be as important as delayed vasospasm in predicting complications and long-term morbidity in SAH patients.

Entities:  

Mesh:

Year:  2004        PMID: 15472099     DOI: 10.1161/01.STR.0000144654.79393.cf

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  23 in total

1.  Depletion of Ly6G/C(+) cells ameliorates delayed cerebral vasospasm in subarachnoid hemorrhage.

Authors:  J Javier Provencio; Tamer Altay; Saksith Smithason; Shari Korday Moore; Richard M Ransohoff
Journal:  J Neuroimmunol       Date:  2010-11-06       Impact factor: 3.478

2.  Early identification of individuals at high risk for cerebral infarction after aneurysmal subarachnoid hemorrhage: the BEHAVIOR score.

Authors:  Ramazan Jabbarli; Matthias Reinhard; Roland Roelz; Mukesch Shah; Wolf-Dirk Niesen; Klaus Kaier; Christian Taschner; Astrid Weyerbrock; Vera Van Velthoven
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-29       Impact factor: 6.200

3.  Blast-induced phenotypic switching in cerebral vasospasm.

Authors:  Patrick W Alford; Borna E Dabiri; Josue A Goss; Matthew A Hemphill; Mark D Brigham; Kevin Kit Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-15       Impact factor: 11.205

Review 4.  Management of cerebral vasospasm.

Authors:  R Loch Macdonald
Journal:  Neurosurg Rev       Date:  2006-02-24       Impact factor: 3.042

5.  Computed tomography perfusion as a predictor of delayed cerebral ischemia and functional outcome in spontaneous subarachnoid hemorrhage: A single center experience.

Authors:  Isabel Fragata; Marta Alves; Ana Luísa Papoila; Ana Paiva Nunes; Patrícia Ferreira; Mariana Diogo; Nuno Canto-Moreira; Patrícia Canhão
Journal:  Neuroradiol J       Date:  2019-02-19

Review 6.  Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature.

Authors:  Guilherme Dabus; Raul G Nogueira
Journal:  Interv Neurol       Date:  2013-10

7.  Cerebral vasospasm and delayed cerebral ischemia in intraventricular hemorrhage.

Authors:  J U Regula; J Schill; P A Ringleb; M Sykora
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

8.  Acute ischemic injury on diffusion-weighted magnetic resonance imaging after poor grade subarachnoid hemorrhage.

Authors:  Katja E Wartenberg; Sheetal J Sheth; J Michael Schmidt; Jennifer A Frontera; Fred Rincon; Noeleen Ostapkovich; Luis Fernandez; Neeraj Badjatia; E Sander Connolly; Alexander Khandji; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

Review 9.  Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought.

Authors:  Ryszard M Pluta; Jacob Hansen-Schwartz; Jens Dreier; Peter Vajkoczy; R Loch Macdonald; Shigeru Nishizawa; Hideotoshi Kasuya; George Wellman; Emanuela Keller; Alois Zauner; Nicholas Dorsch; Joseph Clark; Shigeki Ono; Talat Kiris; Peter Leroux; John H Zhang
Journal:  Neurol Res       Date:  2009-03       Impact factor: 2.448

10.  Intraarterial nimodipine infusion to treat symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Jong Hoon Kim; In Sung Park; Kyung Bum Park; Dong-Ho Kang; Soo Hyun Hwang
Journal:  J Korean Neurosurg Soc       Date:  2009-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.